[{"Assets_0_Q3_USD":23073200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":213300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":211800000.0,"StockholdersEquityConverted_0_Q3_USD":12848900000.0,"StockholdersEquity_0_Q3_USD":12860500000.0,"RevenuesConverted_3_Q3_USD":8966900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":211400000.0,"RevenuesConverted_1_Q3_USD":3077800000.0,"NetIncomeLossConverted_1_Q3_USD":1226100000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":3032700000.0,"EarningsPerShareDiluted_3_Q3_USD":13.3,"EarningsPerShareDiluted_1_Q3_USD":5.79,"EarningsPerShareBasic_3_Q3_USD":13.32,"EarningsPerShareBasic_1_Q3_USD":5.8,"NetIncomeLossConverted_3_Q3_USD":2836400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":213000000.0,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20171024"}]